Quality assurance of drugs used in clinical trials: proposal for adapting guidelines

BMJ. 2015 Feb 25:350:h602. doi: 10.1136/bmj.h602.

Abstract

Paul Newton and colleagues propose that clinical trial guidelines should include a requirement to assess and state the quality of the drugs and other medical products used

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic / standards*
  • Counterfeit Drugs
  • Equipment and Supplies / standards*
  • Guidelines as Topic*
  • Humans
  • Pharmaceutical Preparations / standards*
  • Placebos / standards*

Substances

  • Counterfeit Drugs
  • Pharmaceutical Preparations
  • Placebos